Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Ischemia | 5 | 2013 | 179 | 1.040 |
Why?
|
| Stroke | 3 | 2013 | 274 | 0.810 |
Why?
|
| Brain | 8 | 2013 | 1268 | 0.810 |
Why?
|
| Gemfibrozil | 2 | 2010 | 2 | 0.750 |
Why?
|
| Infarction, Middle Cerebral Artery | 3 | 2009 | 76 | 0.700 |
Why?
|
| Neuroprotective Agents | 2 | 2013 | 231 | 0.690 |
Why?
|
| PPAR alpha | 2 | 2011 | 42 | 0.470 |
Why?
|
| Cerebrovascular Circulation | 2 | 2009 | 71 | 0.440 |
Why?
|
| Microvessels | 1 | 2010 | 31 | 0.380 |
Why?
|
| Reperfusion Injury | 3 | 2009 | 53 | 0.380 |
Why?
|
| Middle Cerebral Artery | 2 | 2009 | 16 | 0.370 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2011 | 112 | 0.370 |
Why?
|
| Blood-Brain Barrier | 2 | 2009 | 153 | 0.370 |
Why?
|
| Superoxide Dismutase | 1 | 2010 | 149 | 0.360 |
Why?
|
| Inflammation Mediators | 1 | 2011 | 120 | 0.360 |
Why?
|
| Brain Infarction | 1 | 2009 | 20 | 0.360 |
Why?
|
| Lipopolysaccharides | 1 | 2011 | 200 | 0.360 |
Why?
|
| Bone Marrow Cells | 1 | 2009 | 75 | 0.350 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2009 | 88 | 0.340 |
Why?
|
| Ischemia | 1 | 2008 | 45 | 0.320 |
Why?
|
| Mice | 9 | 2011 | 5668 | 0.310 |
Why?
|
| Retina | 1 | 2008 | 255 | 0.270 |
Why?
|
| Mice, Inbred C57BL | 4 | 2011 | 1530 | 0.240 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 58 | 0.240 |
Why?
|
| Stilbenes | 1 | 2003 | 41 | 0.230 |
Why?
|
| Kainic Acid | 1 | 2002 | 47 | 0.220 |
Why?
|
| Excitatory Amino Acid Transporter 2 | 1 | 2002 | 25 | 0.220 |
Why?
|
| Animals | 9 | 2011 | 14307 | 0.210 |
Why?
|
| Brain Edema | 1 | 2002 | 62 | 0.210 |
Why?
|
| Neuroglia | 1 | 2002 | 117 | 0.200 |
Why?
|
| Glutamic Acid | 1 | 2002 | 115 | 0.200 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2009 | 63 | 0.170 |
Why?
|
| Triglycerides | 2 | 2009 | 129 | 0.170 |
Why?
|
| Mice, Knockout | 3 | 2010 | 897 | 0.170 |
Why?
|
| Transcription Factors | 1 | 2003 | 653 | 0.170 |
Why?
|
| Male | 8 | 2011 | 18870 | 0.160 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 605 | 0.160 |
Why?
|
| Cholesterol | 2 | 2009 | 194 | 0.160 |
Why?
|
| Gene Expression | 2 | 2009 | 639 | 0.140 |
Why?
|
| RNA, Messenger | 2 | 2010 | 1152 | 0.130 |
Why?
|
| Injections, Intraventricular | 2 | 2011 | 60 | 0.110 |
Why?
|
| Stem Cell Transplantation | 1 | 2013 | 31 | 0.110 |
Why?
|
| PPAR gamma | 1 | 2010 | 49 | 0.090 |
Why?
|
| Pyrimidines | 1 | 2011 | 112 | 0.090 |
Why?
|
| Antipyrine | 1 | 2009 | 3 | 0.090 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2009 | 5 | 0.090 |
Why?
|
| Cerebral Infarction | 1 | 2009 | 17 | 0.090 |
Why?
|
| Autoradiography | 1 | 2009 | 36 | 0.090 |
Why?
|
| Transplantation Chimera | 1 | 2009 | 7 | 0.090 |
Why?
|
| Gelatinases | 1 | 2009 | 8 | 0.090 |
Why?
|
| Bone Marrow Transplantation | 1 | 2009 | 15 | 0.090 |
Why?
|
| Capillaries | 1 | 2009 | 29 | 0.090 |
Why?
|
| Capillary Permeability | 1 | 2009 | 30 | 0.090 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2009 | 13 | 0.090 |
Why?
|
| Animals, Genetically Modified | 1 | 2009 | 93 | 0.090 |
Why?
|
| Radiopharmaceuticals | 1 | 2009 | 55 | 0.090 |
Why?
|
| Body Temperature | 1 | 2009 | 39 | 0.090 |
Why?
|
| Amaurosis Fugax | 1 | 2008 | 1 | 0.080 |
Why?
|
| Isoflurane | 1 | 2008 | 3 | 0.080 |
Why?
|
| Models, Anatomic | 1 | 2008 | 22 | 0.080 |
Why?
|
| Aorta | 1 | 2009 | 161 | 0.080 |
Why?
|
| Microspheres | 1 | 2008 | 45 | 0.080 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2008 | 126 | 0.080 |
Why?
|
| Oxygen Consumption | 1 | 2008 | 98 | 0.080 |
Why?
|
| RNA | 1 | 2009 | 234 | 0.080 |
Why?
|
| Microscopy, Fluorescence | 1 | 2008 | 240 | 0.080 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 608 | 0.070 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 1300 | 0.070 |
Why?
|
| Treatment Outcome | 1 | 2009 | 1349 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2010 | 874 | 0.060 |
Why?
|
| Time Factors | 1 | 2009 | 1681 | 0.060 |
Why?
|
| Haplorhini | 1 | 2003 | 21 | 0.060 |
Why?
|
| alpha-Macroglobulins | 1 | 2003 | 1 | 0.060 |
Why?
|
| Neurotransmitter Uptake Inhibitors | 1 | 2002 | 1 | 0.060 |
Why?
|
| Ischemic Attack, Transient | 1 | 2002 | 20 | 0.050 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2002 | 31 | 0.050 |
Why?
|
| Water-Electrolyte Balance | 1 | 2002 | 17 | 0.050 |
Why?
|
| Extracellular Space | 1 | 2002 | 33 | 0.050 |
Why?
|
| Cattle | 1 | 2003 | 472 | 0.050 |
Why?
|
| Neurotoxins | 1 | 2002 | 52 | 0.050 |
Why?
|
| Amides | 1 | 2002 | 66 | 0.050 |
Why?
|
| Astrocytes | 1 | 2003 | 203 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 984 | 0.050 |
Why?
|
| Apoptosis | 1 | 2008 | 1317 | 0.050 |
Why?
|
| Endothelial Cells | 1 | 2003 | 296 | 0.050 |
Why?
|
| Humans | 3 | 2013 | 34853 | 0.040 |
Why?
|
| Injections, Intra-Arterial | 1 | 2003 | 5 | 0.010 |
Why?
|
| Osmosis | 1 | 2003 | 7 | 0.010 |
Why?
|
| Mannitol | 1 | 2003 | 11 | 0.010 |
Why?
|
| Permeability | 1 | 2003 | 67 | 0.010 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2003 | 79 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 2003 | 96 | 0.010 |
Why?
|
| Female | 1 | 2002 | 19873 | 0.010 |
Why?
|
| Chemokine CCL4 | 1 | 2002 | 18 | 0.010 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 2002 | 14 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2002 | 58 | 0.010 |
Why?
|
| Peroxidase | 1 | 2002 | 50 | 0.010 |
Why?
|
| Chromatography, Liquid | 1 | 2003 | 140 | 0.010 |
Why?
|
| Leukocytes | 1 | 2002 | 68 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 2003 | 105 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2003 | 255 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2002 | 859 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2003 | 1442 | 0.010 |
Why?
|